 | • レポートコード：QY20ST-03796 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の喘息予防市場について種類別（クロモリンナトリウム、プレドニゾロン）、用途別（子供、大人）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・喘息予防市場の概要 ・世界の主要地域別喘息予防市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の喘息予防市場規模2015-2026：種類別（クロモリンナトリウム、プレドニゾロン） ・世界の喘息予防市場規模2015-2026：用途別（子供、大人） ・喘息予防の北米市場規模2015-2020 ・喘息予防のヨーロッパ市場規模2015-2020 ・喘息予防の中国市場規模2015-2020 ・喘息予防の日本市場規模2015-2020 ・喘息予防の東南アジア市場規模2015-2020 ・喘息予防のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・喘息予防の製造コスト分析 ・販売チャネル、流通業者、顧客 ・喘息予防の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Asthma Preventive Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Asthma Preventive market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Asthma Preventive market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Asthma Preventive industry.
Based on our recent survey, we have several different scenarios about the Asthma Preventive YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Asthma Preventive will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Asthma Preventive market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Asthma Preventive market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Asthma Preventive market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Asthma Preventive market. The report also includes nautical information, where it shows Asthma Preventive market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Asthma Preventive market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Asthma Preventive market.
Geographical Analysis:
Based on region, the global Asthma Preventive market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Asthma Preventive market are
Pfizer
Abbot
Novartis
Roche
GSK
Merck
Astrazeneca
Biotest AG
Boehringer Ingelheim
Chiesi
Sumitomo Dainippon Pharma
Amgen
Segment by Type
Sodium Cromolyn
Prednisolone
Segment by Application
Children
Adult
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Asthma Preventive market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Asthma Preventive market.
• The market share of the global Asthma Preventive market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Asthma Preventive market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Asthma Preventive market.
1 Asthma Preventive Market Overview
1.1 Asthma Preventive Product Scope
1.2 Asthma Preventive Segment by Type
1.2.1 Global Asthma Preventive Sales by Type (2020-2026)
1.2.2 Sodium Cromolyn
1.2.3 Prednisolone
1.3 Asthma Preventive Segment by Application
1.3.1 Global Asthma Preventive Sales Comparison by Application (2020-2026)
1.3.2 Children
1.3.3 Adult
1.4 Asthma Preventive Market Estimates and Forecasts (2015-2026)
1.4.1 Global Asthma Preventive Sales Growth Rate (2015-2026)
1.4.2 Global Asthma Preventive Revenue and Growth Rate (2015-2026)
1.4.3 Global Asthma Preventive Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Asthma Preventive Industry Impact
1.5.1 How the Covid-19 is Affecting the Asthma Preventive Industry
1.5.1.1 Asthma Preventive Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Asthma Preventive Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Asthma Preventive Players to Combat Covid-19 Impact
2 Asthma Preventive Estimate and Forecast by Region
2.1 Global Asthma Preventive Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Asthma Preventive Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Asthma Preventive Sales Market Share by Region (2015-2020)
2.2.2 Global Asthma Preventive Revenue Market Share by Region (2015-2020)
2.3 Global Asthma Preventive Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Asthma Preventive Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Asthma Preventive Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Asthma Preventive Estimates and Projections (2015-2026)
2.4.2 Europe Asthma Preventive Estimates and Projections (2015-2026)
2.4.3 China Asthma Preventive Estimates and Projections (2015-2026)
2.4.4 Japan Asthma Preventive Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Asthma Preventive Estimates and Projections (2015-2026)
2.4.6 India Asthma Preventive Estimates and Projections (2015-2026)
3 Global Asthma Preventive Competition Landscape by Players
3.1 Global Top Asthma Preventive Players by Sales (2015-2020)
3.2 Global Top Asthma Preventive Players by Revenue (2015-2020)
3.3 Global Asthma Preventive Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Preventive as of 2019)
3.4 Global Asthma Preventive Average Price by Company (2015-2020)
3.5 Manufacturers Asthma Preventive Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Asthma Preventive Players (Opinion Leaders)
4 Global Asthma Preventive Market Size by Type
4.1 Global Asthma Preventive Historic Market Review by Type (2015-2020)
4.1.1 Global Asthma Preventive Sales Market Share by Type (2015-2020)
4.1.2 Global Asthma Preventive Revenue Market Share by Type (2015-2020)
4.1.3 Global Asthma Preventive Price by Type (2014-2020)
4.2 Global Asthma Preventive Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Asthma Preventive Sales Forecast by Type (2021-2026)
4.2.2 Global Asthma Preventive Revenue Forecast by Type (2021-2026)
4.2.3 Global Asthma Preventive Price Forecast by Type (2021-2026)
5 Global Asthma Preventive Market Size by Application
5.1 Global Asthma Preventive Historic Market Review by Application (2015-2020)
5.1.1 Global Asthma Preventive Sales Market Share by Application (2015-2020)
5.1.2 Global Asthma Preventive Revenue Market Share by Application (2015-2020)
5.1.3 Global Asthma Preventive Price by Application (2015-2020)
5.2 Global Asthma Preventive Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Asthma Preventive Sales Forecast by Application (2021-2026)
5.2.2 Global Asthma Preventive Revenue Forecast by Application (2021-2026)
5.2.3 Global Asthma Preventive Price Forecast by Application (2021-2026)
3 North America Asthma Preventive Market Facts & Figures
3.2 North America Asthma Preventive Sales Market Share by Company (2015-2020)
3.3 North America Asthma Preventive Sales Market Share by Type (2015-2020)
3.4 North America Asthma Preventive Sales Market Share by Application (2015-2020)
4 Europe Asthma Preventive Market Facts & Figures
4.2 Europe Asthma Preventive Sales Market Share by Company (2015-2020)
4.3 Europe Asthma Preventive Sales Market Share by Type (2015-2020)
4.4 Europe Asthma Preventive Sales Market Share by Application (2015-2020)
5 China Asthma Preventive Market Facts & Figures
5.2 China Asthma Preventive Sales Market Share by Company (2015-2020)
5.3 China Asthma Preventive Sales Market Share by Type (2015-2020)
5.4 China Asthma Preventive Sales Market Share by Application (2015-2020)
6 Japan Asthma Preventive Market Facts & Figures
6.2 Japan Asthma Preventive Sales Market Share by Company (2015-2020)
6.3 Japan Asthma Preventive Sales Market Share by Type (2015-2020)
6.4 Japan Asthma Preventive Sales Market Share by Application (2015-2020)
7 Southeast Asia Asthma Preventive Market Facts & Figures
7.2 Southeast Asia Asthma Preventive Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Asthma Preventive Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Asthma Preventive Sales Market Share by Application (2015-2020)
8 India Asthma Preventive Market Facts & Figures
8.2 India Asthma Preventive Sales Market Share by Company (2015-2020)
8.3 India Asthma Preventive Sales Market Share by Type (2015-2020)
8.4 India Asthma Preventive Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Asthma Preventive Business
12.1 Pfizer
12.1.1 Pfizer Asthma Preventive Corporation Information
12.1.2 Pfizer Asthma Preventive Business Overview and Total Revenue
12.1.3 Pfizer Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Asthma Preventive Products Offered
12.1.5 Pfizer Recent Development
12.2 Abbot
12.2.1 Abbot Asthma Preventive Corporation Information
12.2.2 Abbot Asthma Preventive Business Overview and Total Revenue
12.2.3 Abbot Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbot Asthma Preventive Products Offered
12.2.5 Abbot Recent Development
12.3 Novartis
12.3.1 Novartis Asthma Preventive Corporation Information
12.3.2 Novartis Asthma Preventive Business Overview and Total Revenue
12.3.3 Novartis Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Asthma Preventive Products Offered
12.3.5 Novartis Recent Development
12.4 Roche
12.4.1 Roche Asthma Preventive Corporation Information
12.4.2 Roche Asthma Preventive Business Overview and Total Revenue
12.4.3 Roche Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Roche Asthma Preventive Products Offered
12.4.5 Roche Recent Development
12.5 GSK
12.5.1 GSK Asthma Preventive Corporation Information
12.5.2 GSK Asthma Preventive Business Overview and Total Revenue
12.5.3 GSK Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GSK Asthma Preventive Products Offered
12.5.5 GSK Recent Development
12.6 Merck
12.6.1 Merck Asthma Preventive Corporation Information
12.6.2 Merck Asthma Preventive Business Overview and Total Revenue
12.6.3 Merck Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck Asthma Preventive Products Offered
12.6.5 Merck Recent Development
12.7 Astrazeneca
12.7.1 Astrazeneca Asthma Preventive Corporation Information
12.7.2 Astrazeneca Asthma Preventive Business Overview and Total Revenue
12.7.3 Astrazeneca Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Astrazeneca Asthma Preventive Products Offered
12.7.5 Astrazeneca Recent Development
12.8 Biotest AG
12.8.1 Biotest AG Asthma Preventive Corporation Information
12.8.2 Biotest AG Asthma Preventive Business Overview and Total Revenue
12.8.3 Biotest AG Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Biotest AG Asthma Preventive Products Offered
12.8.5 Biotest AG Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Asthma Preventive Corporation Information
12.9.2 Boehringer Ingelheim Asthma Preventive Business Overview and Total Revenue
12.9.3 Boehringer Ingelheim Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Boehringer Ingelheim Asthma Preventive Products Offered
12.9.5 Boehringer Ingelheim Recent Development
12.10 Chiesi
12.10.1 Chiesi Asthma Preventive Corporation Information
12.10.2 Chiesi Asthma Preventive Business Overview and Total Revenue
12.10.3 Chiesi Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Chiesi Asthma Preventive Products Offered
12.10.5 Chiesi Recent Development
12.11 Sumitomo Dainippon Pharma
12.11.1 Sumitomo Dainippon Pharma Asthma Preventive Corporation Information
12.11.2 Sumitomo Dainippon Pharma Asthma Preventive Business Overview and Total Revenue
12.11.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sumitomo Dainippon Pharma Asthma Preventive Products Offered
12.11.5 Sumitomo Dainippon Pharma Recent Development
12.12 Amgen
12.12.1 Amgen Asthma Preventive Corporation Information
12.12.2 Amgen Asthma Preventive Business Overview and Total Revenue
12.12.3 Amgen Asthma Preventive Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Amgen Asthma Preventive Products Offered
12.12.5 Amgen Recent Development
13 Asthma Preventive Manufacturing Cost Analysis
13.1 Asthma Preventive Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Asthma Preventive
13.4 Asthma Preventive Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Asthma Preventive Distributors List
14.3 Asthma Preventive Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Asthma Preventive Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Asthma Preventive Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Asthma Preventive Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Asthma Preventive Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Asthma Preventive Players to Combat Covid-19 Impact
Table 8. Global Market Asthma Preventive Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Asthma Preventive Sales (K Units) by Region (2015-2020)
Table 10. Global Asthma Preventive Sales Market Share by Region (2015-2020)
Table 11. Global Asthma Preventive Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Asthma Preventive Revenue Share by Region (2015-2020)
Table 13. Global Asthma Preventive Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Asthma Preventive Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Asthma Preventive Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Asthma Preventive Revenue Share Forecast by Region (2021-2026)
Table 17. Global Asthma Preventive (K Units) of Key Companies (2015-2020)
Table 18. Global Asthma Preventive Sales Share by Company (2015-2020)
Table 19. Global Asthma Preventive Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Asthma Preventive Revenue Share by Company (2015-2020)
Table 21. Global Asthma Preventive by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Preventive as of 2019)
Table 22. Global Asthma Preventive Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Asthma Preventive Manufacturing Sites and Area Served
Table 24. Manufacturers Asthma Preventive Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Asthma Preventive Players
Table 27. Global Asthma Preventive Sales (K Units) by Type (2015-2020)
Table 28. Global Asthma Preventive Sales Share by Type (2015-2020)
Table 29. Global Asthma Preventive Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Asthma Preventive Price (K Units) by Type (2015-2020)
Table 31. Global Asthma Preventive Sales Share by Type (2021-2026)
Table 32. Global Asthma Preventive Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Asthma Preventive Revenue Share by Type (2021-2026)
Table 34. Global Asthma Preventive Price (K Units) by Type (2021-2026)
Table 35. Global Asthma Preventive Sales (K Units) by Application (2015-2020)
Table 36. Global Asthma Preventive Sales Share by Application (2015-2020)
Table 37. Global Asthma Preventive Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Asthma Preventive Price (K Units) by Application (2015-2020)
Table 39. Global Asthma Preventive Sales (K Units) by Application (2021-2026)
Table 40. Global Asthma Preventive Sales Share by Application (2021-2026)
Table 41. Global Asthma Preventive Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Asthma Preventive Revenue Share by Application (2021-2026)
Table 43. Global Asthma Preventive Price (K Units) by Application (2021-2026)
Table 44. United States Asthma Preventive Sales (K Units) by Company (2015-2020)
Table 45. United States Asthma Preventive Sales Market Share by Company (2015-2020)
Table 46. United States Asthma Preventive Sales (K Units) by Type (2015-2020)
Table 47. United States Asthma Preventive Sales Market Share by Type (2015-2020)
Table 48. United States Asthma Preventive Sales (K Units) by Application (2015-2020)
Table 49. United States Asthma Preventive Sales Market Share by Application (2015-2020)
Table 50. Europe Asthma Preventive Sales (K Units) by Company (2015-2020)
Table 51. Europe Asthma Preventive Sales Market Share by Company (2015-2020)
Table 52. Europe Asthma Preventive Sales (K Units) by Type (2015-2020)
Table 53. Europe Asthma Preventive Sales Market Share by Type (2015-2020)
Table 54. Europe Asthma Preventive Sales (K Units) by Application (2015-2020)
Table 55. Europe Asthma Preventive Sales Market Share by Type (2015-2020)
Table 56. China Asthma Preventive Sales (K Units) by Company (2015-2020)
Table 57. China Asthma Preventive Sales Market Share by Company (2015-2020)
Table 58. China Asthma Preventive Sales (K Units) by Type (2015-2020)
Table 59. China Asthma Preventive Sales Market Share by Type (2015-2020)
Table 60. China Asthma Preventive Sales (K Units) by Application (2015-2020)
Table 61. China Asthma Preventive Sales Market Share by Application (2015-2020)
Table 62. Japan Asthma Preventive Sales (K Units) by Company (2015-2020)
Table 63. Japan Asthma Preventive Sales Market Share by Company (2015-2020)
Table 64. Japan Asthma Preventive Sales (K Units) by Type (2015-2020)
Table 65. Japan Asthma Preventive Sales Market Share by Type (2015-2020)
Table 66. Japan Asthma Preventive Sales (K Units) by Application (2015-2020)
Table 67. Japan Asthma Preventive Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Asthma Preventive Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Asthma Preventive Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Asthma Preventive Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Asthma Preventive Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Asthma Preventive Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Asthma Preventive Sales Market Share by Application (2015-2020)
Table 74. India Asthma Preventive Sales (K Units) by Company (2015-2020)
Table 75. India Asthma Preventive Sales Market Share by Company (2015-2020)
Table 76. India Asthma Preventive Sales (K Units) by Type (2015-2020)
Table 77. India Asthma Preventive Sales Market Share by Type (2015-2020)
Table 78. India Asthma Preventive Sales (K Units) by Application (2015-2020)
Table 79. India Asthma Preventive Sales Market Share by Application (2015-2020)
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Asthma Preventive Product
Table 84. Pfizer Recent Development
Table 85. Abbot Corporation Information
Table 86. Abbot Description and Business Overview
Table 87. Abbot Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Abbot Asthma Preventive Product
Table 89. Abbot Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Asthma Preventive Product
Table 94. Novartis Recent Development
Table 95. Roche Corporation Information
Table 96. Roche Description and Business Overview
Table 97. Roche Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Roche Asthma Preventive Product
Table 99. Roche Recent Development
Table 100. GSK Corporation Information
Table 101. GSK Description and Business Overview
Table 102. GSK Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. GSK Asthma Preventive Product
Table 104. GSK Recent Development
Table 105. Merck Corporation Information
Table 106. Merck Description and Business Overview
Table 107. Merck Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Merck Asthma Preventive Product
Table 109. Merck Recent Development
Table 110. Astrazeneca Corporation Information
Table 111. Astrazeneca Description and Business Overview
Table 112. Astrazeneca Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Astrazeneca Asthma Preventive Product
Table 114. Astrazeneca Recent Development
Table 115. Biotest AG Corporation Information
Table 116. Biotest AG Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Biotest AG Description and Business Overview
Table 118. Biotest AG Asthma Preventive Product
Table 119. Biotest AG Recent Development
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Boehringer Ingelheim Description and Business Overview
Table 123. Boehringer Ingelheim Asthma Preventive Product
Table 124. Boehringer Ingelheim Recent Development
Table 125. Chiesi Corporation Information
Table 126. Chiesi Description and Business Overview
Table 127. Chiesi Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Chiesi Asthma Preventive Product
Table 129. Chiesi Recent Development
Table 130. Sumitomo Dainippon Pharma Corporation Information
Table 131. Sumitomo Dainippon Pharma Description and Business Overview
Table 132. Sumitomo Dainippon Pharma Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Sumitomo Dainippon Pharma Asthma Preventive Product
Table 134. Sumitomo Dainippon Pharma Recent Development
Table . Amgen Corporation Information
Table . Amgen Description and Business Overview
Table . Amgen Asthma Preventive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Amgen Asthma Preventive Product
Table . Amgen Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Asthma Preventive Distributors List
Table 143. Asthma Preventive Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Asthma Preventive Product Picture
Figure 2. Global Asthma Preventive Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Asthma Preventive Market Share by Application in 2020 & 2026
Figure 6. Children Examples
Figure 7. Adult Examples
Figure 8. Global Asthma Preventive Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Asthma Preventive Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Asthma Preventive Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Asthma Preventive Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Asthma Preventive Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Asthma Preventive Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Asthma Preventive Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Asthma Preventive Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Asthma Preventive Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Asthma Preventive Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Asthma Preventive Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Asthma Preventive Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Asthma Preventive Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Asthma Preventive Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Asthma Preventive Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Asthma Preventive Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Asthma Preventive Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Asthma Preventive Players Market Share by Revenue in Asthma Preventive 2015 & 2019
Figure 26. Asthma Preventive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Asthma Preventive Revenue Share by Type (2015-2020)
Figure 28. Global Asthma Preventive Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Asthma Preventive Revenue Share by Application (2015-2020)
Figure 30. Global Asthma Preventive Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Asthma Preventive Sales Market Share by Type in 2019
Figure 32. United States Asthma Preventive Sales Market Share by Type in 2019
Figure 33. Europe Asthma Preventive Sales Market Share by Company in 2019
Figure 34. Europe Asthma Preventive Sales Market Share by Type in 2019
Figure 35. Europe Asthma Preventive Sales Market Share by Application in 2019
Figure 36. China Asthma Preventive Sales Market Share by Company in 2019
Figure 37. China Asthma Preventive Sales Market Share by Type in 2019
Figure 38. China Asthma Preventive Sales Market Share by Application in 2019
Figure 39. Japan Asthma Preventive Sales Market Share by Company in 2019
Figure 40. Japan Asthma Preventive Sales Market Share by Type in 2019
Figure 41. Japan Asthma Preventive Sales Market Share by Application in 2019
Figure 42. Southeast Asia Asthma Preventive Sales Market Share by Company in 2019
Figure 43. Southeast Asia Asthma Preventive Sales Market Share by Type in 2019
Figure 44. Southeast Asia Asthma Preventive Sales Market Share by Application in 2019
Figure 45. India Asthma Preventive Sales Market Share by Company in 2019
Figure 46. India Asthma Preventive Sales Market Share by Type in 2019
Figure 47. India Asthma Preventive Sales Market Share by Application in 2019
Figure 48. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Abbot Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Biotest AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Chiesi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Sumitomo Dainippon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Asthma Preventive
Figure 62. Manufacturing Process Analysis of Asthma Preventive
Figure 63. Asthma Preventive Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
喘息予防の世界市場レポート2020 A recently published report by QY Research titled Global Asthma Preventive Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …- 喘息予防の世界市場レポート2020 Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease. Market Analysis and Insights: Global Asthma Preventive Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countrie…
- 喘息予防の世界市場レポート2020 Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease. Market Analysis and Insights: Global Asthma Preventive Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countrie…
- 予防ワクチンの世界市場レポート2020 Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease. Market Analysis and Insights: Global Preventive Vaccines Market Since t…
- 喘息吸入器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Asthma Inhaler Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Asthma Inhaler Device m…